FrancophonIA/ELRC3.0 huggingface dataset:
English: The following properties have been demonstrated in preclinical studies: - In vivo: Inhibition of osteoclastic bone resorption, which alters the bone marrow microenvironment, making it less conducive to tumour cell growth, anti-angiogenic activity and anti-pain activity.
Croatian: U nekliničkim ispitivanjima pokazala je sljedeća svojstva: in vivo: inhibicija osteoklastične resorpcije kosti, koja mijenja mikrookoliš koštane srži i čini je manje pogodnom za rast tumorskih stanica, antiangiogeno djelovanje i analgetsko djelovanje. in vitro: inhibicija proliferacije osteoblasta, izravno citostatsko i proapoptotsko djelovanje na tumorske stanice, sinergistički citostatski učinak s drugim antitumorskim lijekovima, antiadhezivno/antiinvazivno djelovanje.
English: Hypocalcaemia has been reported in patients treated with Zometa.
Croatian: U bolesnika liječenih Zometom zabilježena je hipokalcemija.
English: - 4.1 ml for 3.3 mg dose
Croatian: - 4,1 ml za dozu od 3,3 mg
English: After dilution: From a microbiological point of view, the diluted solution for infusion should be used immediately.
Croatian: Nakon razrjeđivanja: S mikrobiološkog stajališta, razrijeđena otopina za infuziju treba se primijeniti odmah.
English: Efficacy results are provided in Table 4.
Croatian: Rezultati djelotvornosti prikazani su u Tablici 4.
English: The other ingredients are mannitol, sodium citrate, water for injections.
Croatian: Drugi sastojci su manitol, natrijev citrat, voda za injekcije.
English: Acute renal failure, haematuria, proteinuria
Croatian: Akutno zatajenje bubrega, hematurija, proteinurija
English: 3.8 ml for 3.0 mg dose
Croatian: 3,8 ml za dozu od 3,0 mg
English: Zoledronic acid 4 mg (N=86) 45.3% (p=0.104)
Croatian: 45,3% (p=0,104)
English: - 3.8 ml for 3.0 mg dose
Croatian: - 3,8 ml za dozu od 3,0 mg
English: If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C - 8°C.
Croatian: Ako se ne primijeni odmah, vrijeme čuvanja i uvjeti čuvanja do primjene odgovornost su korisnika i normalno ne smiju biti duži od 24 sata pri 2°C - 8°C.
English: Zometa 4 mg/100 ml solution for infusion zoledronic acid
Croatian: Zometa 4 mg/100 ml otopina za infuziju zoledronatna kiselina
English: Efficacy results are provided in Table 2.
Croatian: Rezultati djelotvornosti prikazani su u Tablici 2.
English: Zoledronic acid was teratogenic in the rat at subcutaneous doses  0.2 mg/kg.
Croatian: Zoledronatna kiselina primijenjena supkutano u dozama ≥0,2 mg/kg u štakora pokazala je teratogeno djelovanje.
English: The withdrawn amount of reconstituted solution must be diluted in 100 ml of sterile 0.9% w/v sodium chloride solution or 5% w/v glucose solution.
Croatian: Izvučenu količinu rekonstituirane otopine treba razrijediti u 100 ml sterilne 0,9% w/v otopine natrijevog klorida ili 5% w/v otopine glukoze.
English: The amount of reconstituted solution as required is then further diluted with 100 ml of calcium-free infusion solution (0.9% w/v sodium chloride solution or 5% w/v glucose solution).
Croatian: Količina rekonstituirane otopine koja je potrebna zatim se dodatno razrijedi sa 100 ml otopine za infuziju koja ne sadrži kalcij (0,9% m/V otopine natrijevog klorida ili 5% m/V otopine glukoze).
English: To avoid potential incompatibilities, the infusion solution used for dilution must be either 0.9% w/v sodium chloride or 5% w/v glucose solution.
Croatian: Da biste izbjegli moguće inkompatibilnosti, otopina za infuziju koja se koristi za razrjeđenje mora biti 0,9% otopina natrijevog klorida ili 5% otopina glukoze.
English: The other ingredients are mannitol, sodium citrate and water for injections.
Croatian: Drugi sastojci su manitol, natrijev citrat i voda za injekcije.
English: Efficacy results are provided in Table 3.
Croatian: Rezultati djelotvornosti prikazani su u Tablici 3.
English: From a microbiological point of view, the diluted solution for infusion should be used immediately.
Croatian: S mikrobiološkog stajališta, razrijeđena otopina za infuziju treba se primijeniti odmah.
English: Only clear solution free from particles and discolouration should be used.
Croatian: Smije se koristiti samo bistra otopina koja ne sadrži čestice i nije promijenila boju.
English: Replace with the following volume of sterile sodium chloride 9 mg/ml (0,9%) or 5% glucose solution for injection (ml)
Croatian: Zamijenite sljedećim volumenom sterilne 0,9% (9 mg/ml) otopine natrijevog klorida ili 5% otopine glukoze za injekciju (ml)
English: Zometa concentrate must not be mixed with calcium or other divalent cation-containing infusion solutions such as lactated Ringer's solution, and should be administered as a single intravenous solution in a separate infusion line.
Croatian: Koncentrat Zomete ne smije se miješati s kalcijem ili drugim otopinama za infuziju koje sadrže dvovalentne katione, kao što je otopina Ringerovog laktata, i treba se primijeniti kao jednokratna intravenska otopina kroz posebnu infuzijsku liniju.
English: Clinical trial results in the treatment of TIH
Croatian: Rezultati kliničkih ispitivanja liječenja hiperkalcemije izazvane tumorom
English: Withdraw the appropriate volume of the reconstituted solution (4 mg/5 ml), as follows: 4.4 ml for 3.5 mg dose
Croatian: Izvucite sljedeći odgovarajući volumen rekonstituirane otopine (4 mg/5 ml), kako slijedi: 4,4 ml za dozu od 3,5 mg
English: Zometa reconstituted solution must not be mixed with calcium or other divalent cation-containing infusion solutions such as lactated Ringer's solution, and should be administered as a single intravenous solution in a separate infusion line.
Croatian: Rekonstituirana otopina Zomete ne smije se miješati s kalcijem ili drugim otopinama za infuziju koje sadrže dvovalentne katione, kao što je otopina Ringerovog laktata, i treba se primijeniti kao jednokratna intravenska otopina kroz posebnu infuzijsku liniju.
English: Zometa 4 mg powder and solvent for solution for infusion
Croatian: Zometa 4 mg prašak i otapalo za otopinu za infuziju
English: Serum calcium should be measured and hypocalcaemia must be corrected before initiating Zometa therapy.
Croatian: Prije uvođenja terapije Zometom potrebno je odrediti razinu kalcija u serumu i korigirati hipokalcemiju.
English: This medicinal product must not be mixed with calcium or other divalent cation-containing infusion solutions such as lactated Ringer's solution, and should be administered as a single intravenous solution in a separate infusion line.
Croatian: Lijek se ne smije miješati s infuzijskim otopinama koje sadrže kalcij ili druge dvovalentne katione kao što je Ringerova otopina s laktatom i treba se primijeniti kao pojedinačna intravenska otopina putem odvojene infuzijske linije.
English: The refrigerated solution should then be equilibrated to room temperature prior to administration.
Croatian: Prije primjene, rashlađenu otopinu treba pustiti da dosegne sobnu temperaturu.
English: Withdraw an appropriate volume of the concentrate needed, as follows: - 4.4 ml for 3.5 mg dose
Croatian: Izvucite odgovarajući volumen koncentrata, kako slijedi: - 4,4 ml za dozu od 3,5 mg
English: You should not be given Zometa if you are pregnant.
Croatian: Ako ste trudni, ne smijete primati Zometu.
English: Zometa 4 mg powder for solution for infusion zoledronic acid
Croatian: Zometa 4 mg prašak za otopinu za infuziju zoledronatna kiselina
English: Prevention of skeletal related events in patients with advanced malignancies involving bone Adults and older people
Croatian: Sprječavanje koštanih događaja u bolesnika s uznapredovalom zloćudnom bolešću koja je zahvatila kosti
English: Withdraw the appropriate volume of the liquid concentrate, as follows: 4.4 ml for 3.5 mg dose
Croatian: Izvucite sljedeći odgovarajući volumen tekućeg koncentrata, kako slijedi: 4,4 ml za dozu od 3,5 mg
English: Radiation therapy to bone zoledronic acid 4 mg
Croatian: Radioterapija kosti zoledronatna kiselina 4 mg
English: Respiratory, thoracic and mediastinal disorders Common:
Croatian: Tahikardija Poremećaji dišnog sustava, prsišta i sredoprsja Često:
English: Severe bone, joint and/or muscle pain, occasionally incapacitating.
Croatian: Jaki, ponekad onesposobljavajući bolovi u kostima, zglobovima i/ili mišićima.
English: Multipack comprising 5 packs, each containing 1 bottle.
Croatian: Višestruko pakiranje sadrži 5 pakiranja, od kojih svako sadrži 1 bocu.
English: One vial with 5 ml concentrate contains 4 mg zoledronic acid, corresponding to 4.264 mg zoledronic acid monohydrate.
Croatian: Jedna bočica s 5 ml koncentrata sadrži 4 mg zoledronatne kiseline, što odgovara 4,264 mg zoledronatne kiseline hidrata.
English: Muscle spasms, osteonecrosis of the jaw
Croatian: Mišićni spazmi, osteonekroza čeljusti
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE NALJEPNICA NA AMPULI
English: Common (may affect up to 1 in 10 people):
Croatian: Često (može se javiti u do 1 na 10 osoba):
English: Component of a multipack comprising 4 packs, each containing 1 bottle.
Croatian: Sastavni dio višestrukog pakiranja koje se sastoji od 4 pakiranja, od kojih svako sadrži po 1 bocu.
English: Do not mix Zometa concentrate with calcium-containing or other divalent cationcontaining solutions such as lactated Ringer's solution.
Croatian: Koncentrat Zomete se ne smije miješati s otopinama koje sadrže kalcij ili druge dvovalentne katione kao što je Ringerova otopina s laktatom.
English: To avoid potential incompatibilities, Zometa concentrate is to be diluted with 0.9% w/v sodium chloride solution or 5% w/v glucose solution.
Croatian: Kako bi se izbjegle moguće inkompatibilnosti, koncentrat Zomete mora se razrijediti s 0,9% m/V otopinom natrijevog klorida ili s 5% m/V otopinom glukoze.
English: Musculoskeletal and connective tissue disorders Common:
Croatian: Bolovi u trbuhu Poremećaji mišićno-koštanog sustava i vezivnog tkiva Često:
English: Component of a multipack comprising 5 packs, each containing 1 bottle.
Croatian: Sastavni dio višestrukog pakiranja koje se sastoji od 5 pakiranja, od kojih svako sadrži po 1 bocu.
English: Multipack comprising 4 packs, each containing 1 bottle.
Croatian: Višestruko pakiranje sadrži 4 pakiranja, od kojih svako sadrži 1 bocu.
English: Headache and a flu-like syndrome consisting of fever, fatigue, weakness, drowsiness, chills and bone, joint and/or muscle ache.
Croatian: Glavobolja i sindrom sličan gripi koji se sastoji od vrućice, umora, slabosti, omamljenosti, zimice i bolova u kostima, zglobovima i/ili mišićima; u većini slučajeva nije potrebno posebno liječenje, i simptomi nestaju nakon kratkog vremena (nekoliko sati ili dana).
English: if you have or have had pain, swelling or numbness of the jaw, a feeling of heaviness in the jaw or loosening of a tooth.
Croatian: ako osjećate ili ste osjećali bol, oticanje ili utrnulost čeljusti, težinu u čeljusti ili klimanje zuba.
English: To avoid potential incompatibilities, Zometa reconstituted solution is to be diluted with 0.9% w/v sodium chloride solution or 5% w/v glucose solution.
Croatian: Kako bi se izbjegle moguće inkompatibilnosti, rekonstituirana otopine Zomete mora se razrijediti s 0,9% m/V otopinom natrijevog klorida ili s 5% m/V otopinom glukoze.
English: Fractures are often bilateral; therefore the contralateral femur should be examined in bisphosphonate-treated patients who have sustained a femoral shaft fracture.
Croatian: Budući da su prijelomi često obostrani, u bolesnika liječenih bisfosfonatima s prijelomom dijafize bedrene kosti potrebno je pregledati bedrenu kost na suprotnoj strani.
English: BPI mean change from baseline
Croatian: Srednja vrijednost promjene BPI od početne vrijednosti
English: Treatment of TIH
Croatian: NAČIN PRIMJENE LIJEKA
English: Zoledronic acid does not inhibit human P450 enzymes in vitro, shows no biotransformation and in animal studies < 3% of the administered dose was recovered in the faeces, suggesting no relevant role of liver function in the pharmacokinetics of zoledronic acid.
Croatian: <3% primijenjene doze otkrilo se u izmetu, što pokazuje da funkcija jetre nema važnu ulogu u farmakokinetici zoledronatne kiseline.
English: Withdraw an appropriate volume of the reconstituted solution (4 mg/5 ml) as needed: - 4.4 ml for 3.5 mg dose
Croatian: Izvucite sljedeći odgovarajući volumen rekonstituirane otopine (4 mg/5 ml), kako slijedi: - 4,4 ml za dozu od 3,5 mg
English: Do not mix Zometa reconstituted solution with calcium-containing or other divalent cation-containing solutions such as lactated Ringer's solution.
Croatian: Rekonstituirana otopina Zomete ne smije se miješati s otopinama koje sadrže kalcij ili druge dvovalentne katione kao što je Ringerova otopina s laktatom.
English: Multipack comprising ten packs, each containing one vial.
Croatian: Višestruko pakiranje koje se sastoji od deset pakiranja, od kojih svako sadrži po jednu bočicu.
English: Zometa 4 mg powder and solvent for solution for infusion zoledronic acid
Croatian: Zometa 4 mg prašak i otapalo za otopinu za infuziju zoledronatna kiselina
English: Gastrointestinal disorders Very common:
Croatian: Poremećaji probavnog sustava Vrlo često:
English: Osteonecrosis of the jaw
Croatian: Osteonekroza čeljusti
English: FOLDING BOX FOR 1 VIAL AND 1 AMPOULE AS UNIT PACK (INCLUDING BLUE BOX) FOLDING BOX FOR 4 VIALS AND 4 AMPOULES AS UNIT PACK (INCLUDING BLUE BOX
Croatian: KUTIJA ZA 4 BOČICE I 4 AMPULE KAO JEDINIČNO PAKIRANJE (UKLJUČUJUĆI PLAVI OKVIR)
English: NR
Croatian: C.
English: How much Zometa is given - The usual single dose given is 4 mg. - If you have a kidney problem, your doctor will give you a lower dose depending on the severity of your kidney problem.
Croatian: - Ako imate tegobe s bubrezima, liječnik će Vam dati nižu dozu ovisno o težini tegoba koje imate s bubrezima.
English: LABELLING AND PACKAGE LEAFLET
Croatian: Kako Zometa izgleda i sadržaj pakiranja
English: Skeletal morbidity rate p-value
Croatian: Stopa koštanog pobola 1,04 p-vrijednosti
English: The adverse reactions ranked under headings of frequency, are presented in Table 6.
Croatian: Nuspojave navedene prema učestalosti prikazane su u Tablici
English: Uncommon (may affect up to 1 in 100 people):
Croatian: Manje često (može se javiti u do 1 na 100 osoba):
English: Atypical fractures of the femur
Croatian: Atipični prijelomi bedrene kosti
English: Sodium citrate Water for injections
Croatian: 6.1 Popis pomoćnih tvari manitol natrijev citrat voda za injekcije
English: 1 bottle contains 4 mg zoledronic acid, corresponding to 4.264 mg zoledronic acid monohydrate.
Croatian: 1 boca sadrži 4 mg zoledronatne kiseline, što odgovara 4,264 mg zoledronatne kiseline hidrata.
English: One bottle contains 4 mg zoledronic acid, corresponding to 4.264 mg zoledronic acid monohydrate.
Croatian: Jedna boca sadrži 4 mg zoledronatne kiseline, što odgovara 4,264 mg zoledronatne kiseline hidrata.
English: Contact your doctor if you experience pain, weakness or discomfort in your thigh, hip or groin as this may be an early indication of a possible fracture of the thigh bone.
Croatian: Rijetko može nastati neuobičajen prijelom bedrene kosti osobito u bolesnika koji se dugotrajno liječe zbog osteoporoze; osjetite li bol, slabost ili nelagodu u natkoljenici, kuku ili preponama, odmah se javite liječniku, jer to mogu biti rani znakovi mogućeg prijeloma bedrene kosti.
English: How Zometa is used
Croatian: Koliko se često daje Zometa
English: Renal function impairment
Croatian: Oštećenje funkcije bubrega
English: Proportion of patients with SREs (%) p-value
Croatian: Udio bolesnika s koštanim događajem p-vrijednost Medijan vremena do koštanog događaja (dani)
English: AMPOULE LABEL
Croatian: Prijavljivanje nuspojava
English: Pruritus, rash (including erythematous and macular rash), increased sweating
Croatian: Svrbež, osip (uključujući eritematozni i makularni osip), pojačano znojenje Poremećaji mišićno-koštanog sustava i vezivnog tkiva Često:
English: One vial contains 4 mg zoledronic acid, corresponding to 4.264 mg zoledronic acid monohydrate.
Croatian: Jedna bočica sadrži 4 mg zoledronatne kiseline, što odgovara 4,264 mg zoledronatne kiseline hidrata.
English: This summary was last updated in June 2014.
Croatian: Sažetak je posljednji put dopunjen u lipnju 2014.
English: The measure of effectiveness was levels of antibodies before and after vaccination.
Croatian: Mjera djelotvornosti bila je razina protutijela prije i nakon cijepljenja.
English: Vaccines work by ‘teaching' the immune system (the body's natural defences) how to defend itself against a disease.
Croatian: Cjepivo djeluje „učeći” imunosni sustav (prirodnu obranu tijela) kako da se brani protiv bolesti.
English: Responses in puppies were lower than adult dogs in some cases, because of antibodies inherited from their mothers.
Croatian: Odgovor u štenadi je bio manji nego u odraslih pasa u pojedinim slučajevima, budući da se protutijela nasljeđuju od majki.
English: The dogs were either vaccinated twice with a three or four week interval or they received a single annual booster vaccination.
Croatian: Psi su cijepljeni dva puta u razmaku od tri ili četiri tjedna ili su docijepljeni jednim godišnjim booster cjepivom.
English: In situations where puppies are expected to inherit very high antibody levels from the bitch the vaccination protocol should be planned accordingly.
Croatian: U situacijama kada se očekuje da će štenad naslijediti visoke razine protutijela od kujice, potrebno je primjereno planirati protokol cijepljenja.
English: If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).
Croatian: Ako želite više informacija na temelju preporuka Odbora za veterinarsko-medicinske proizvode (CVMP), pročitajte znanstvenu raspravu (ista je dio Europskoga javnog izvješća o procjeni veterinarsko-medicinskog proizvoda (EPAR)).
English: In the future, if the animals are exposed to these viruses or bacteria again the immune system will be able to respond more quickly.
Croatian: Ubuduće ako se životinje izlože ovim infekcijama, imunosni sustav će brže stvarati protutijela.
English: This will help protect them against kennel cough and leptospirosis.
Croatian: Ovo pomaže pri njihovoj zaštiti od kašlja čopora i leptospiroze.
English: The field study showed that after vaccination with Versican Plus Pi/L4 the percentage of dogs with protective levels of antibodies for parainfluenza virus ranged from 73 to 97% and for leptospira 59 to 96%.
Croatian: Terenskim je ispitivanjem dokazano da se nakon cijepljenja cjepivom Versican Plus Pi/L4 postotak pasa sa zaštitnim razinama protutijela za virusa parainfluence kretao od 73 do 97%, za leptospiru od 59 do 96%.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Versican Plus Pi/L4 on 31 July 2014.
Croatian: Europska komisija dodijelila je odobrenje za stavljanje u promet koje je na snazi na teritoriju Europske unije za proizvod Versican Plus Pi/L4 od 31. srpnja 2014.
English: The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Versican Plus Pi/L4 exceed the risks for the approved indications and recommended that Versican Plus Pi/L4 be given a marketing authorisation.
Croatian: Odbor za veterinarsko-medicinske proizvode (CVMP) zaključio je da koristi lijeka Versican Plus Pi/L4 nadmašuju rizike za odobrene indikacije i preporučilo je izdavanje odobrenja za stavljanje u promet VMP-a Versican Plus Pi/L4.
English: The effectiveness of Versican Plus Pi/L4 was investigated in a field study involving 129 dogs.
Croatian: Djelotvornost cjepiva Versican Plus Pi/L4 ispitana je terenskim ispitivanjem koje je obuhvatilo 129 pasa.
English: Versican Plus Pi/L4 is a veterinary vaccine that contains live attenuated (weakened) canine parainfluenza virus type 2 as well as inactivated (killed) strains of Leptospira bacteria (Icterohaemorrhagiae, Canicola, Bratislava and Grippotyphosa).
Croatian: Versican Plus Pi/L4 je veterinarsko cjepivo koje sadrži živi atenuirani (oslabljeni) virus pseće parainfluence tip 2 kao i inaktivirane (ubijene) sojeve bakterije Leptospira (Icterohaemorrhagiae, Canicola, Bratislava i Grippotyphosa).
English: In case of accidental self-injection, medical advice should be sought immediately and the package leaflet or label shown to the doctor.
Croatian: U slučaju da se nehotice samo injicira, odmah potražiti pomoć liječnika i pokažite mu uputu o VMP ili etiketu.
English: • canine parainfluenza virus, which causes kennel cough;
Croatian: • virusa pseće parainfluence, koji uzrokuje kašalj čopora;
English: When Versican Plus Pi/L4 is given to dogs the animals' immune system recognises the viruses and bacteria as ‘foreign' and makes antibodies against them.
Croatian: U slučaju kada se Versican Plus Pi/L4 primjenjuje u pasa, imunosni sustav životinje prepoznaje viruse i bakterije kao „strane” i proizvodi protutijela protiv virusa i bakterija.
English: The benefit-risk balance may be found in the scientific discussion module of this EPAR.
Croatian: Omjer koristi i rizika dostupan je u modulu znanstvene rasprave ovog EPAR-a.
English: The canine parainfluenza virus in Versican Plus Pi/L4 is alive but has been attenuated (weakened) so that it does not cause disease; it is combined with killed (inactivated) strains of Leptospira bacteria.
Croatian: Virus pseće parainfluence u cjepivu Versican Plus Pi/L4 je živ, ali je atenuiran (oslabljen) tako da ne uzrokuje bolest; kombiniran je s ubijenim (inaktiviranim) sojevima bakterije Leptospira.
English: Versican Plus Pi/L4 contains an adjuvant (aluminium hydroxide) to enhance the immune response.
Croatian: Versican Plus Pi/L4 sadrži adjuvans (aluminijev hidroksid) kako bi se pojačao imunosni odgovor.
English: Canine parainfluenza virus (live attenuated) and canine leptospirosis (inactivated) vaccine
Croatian: Virus pseće parainfluence (živi atenuirani) i cjepivo protiv pseće leptospiroze (inaktivirano)
English: Versican Plus Pi/L4 is used to protect dogs against:
Croatian: Versican Plus Pi/L4R se koristi za zaštitu pasa od:
English: The most common side effect (seen in more than 1 in 100 dogs) with Versican Plus Pi/L4 is a short lived swelling of up to 5 cm which may occur at the injection site after vaccination.
Croatian: Najčešće nuspojave (kod 1 od 100 pasa) lijeka Versican Plus Pi/L4 isu kratkotrajno oticanje do 5 cm koje može nastupiti na mjestu injekcije nakon cijepljenja.
English: For revaccination a single dose of Versican Plus Pi/L4 is required annually.
Croatian: Za docjepljivanje potrebna je jedna doza cjepiva Versican Plus Pi/L4 godišnje.
English: Versican Plus Pi/L4 is a vaccine.
Croatian: Versican Plus Pi/L4 je cjepivo.
English: Versican Plus Pi/L4 is available as a lyophilisate (freeze-dried pellet) with solvent for injection.
Croatian: Versican Plus Pi/L4 dostupan je kao liofilizat (smrzavanjem osušen pelet) s otapalom za injekciju.
English: Other information about Versican Plus Pi/L4:
Croatian: Druge informacije o Versican Plus Pi/L4:
English: What is the risk associated with Versican Plus Pi/L4?
Croatian: Koji su rizici povezani s Versican Plus Pi/L4?
English: What is Versican Plus Pi/L4?
Croatian: Što je Versican Plus Pi/L4?
English: Why has Versican Plus Pi/L4 been approved?
Croatian: Zašto je Versican Plus Pi/L4R odobren?
English: What benefit has Versican Plus Pi/L4 shown during the studies?
Croatian: Koje koristi Versican Plus Pi/L4 su utvrđene tijekom ispitivanja?
English: How has Versican Plus Pi/L4 been studied?
Croatian: Kako se Versican Plus Pi/L4 ispitivao?
English: What is Versican Plus Pi/L4 used for?
Croatian: Za što se Versican Plus Pi/L4 koristi?
English: The vaccine is given to puppies from six weeks of age as an injection, under the skin, and repeated three to four weeks later.
Croatian: • leptospiroze, bakterijske bolesti koja se može prenijeti putem zaraženog urina, a rezultira krvarenjem, hepatitisom (upalom jetre) i žuticom ili nefritisom (upalom bubrega); Cjepivo se primjenjuje u štenadi u dobi od šest tjedana u obliku supkutane injekcije i ponavlja se nakon tri do četiri tjedana.
English: How does Versican Plus Pi/L4 work?
Croatian: Na koji način Versican Plus Pi/L4 djeluje?